“Psoriasis With Leg Involvement, a New Difficult-to-Treat Area: A Cohort Study of Patients Treated With Risankizumab” (2024) Dermatology Practical & Conceptual, 14(3), p. e2024171. doi:10.5826/dpc.1403a171.